Medicine & Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medicine & Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Center Hospital Pitie Salpetriere, Paris, France
Researchers from France, the United States and the United Kingdom provide details of new studies and findings in the area of HIV/AIDS
October 13th, 2006
New findings from France, the United States and the United Kingdom describe advances in HIV/AIDS. Study 1: Standard operating procedures are needed for the quantification of human immunodeficiency virus-specific T cells using a gamma interferon enzyme-linked immunospot assay. According to recent research from France, "The gamma interferon (IFN-gamma) enzyme-linked immunospot (ELISPOT) assay is a reference method for the ex vivo monitoring of antigen-specific T cells and a primary tool for assessing clinical trials of human immunodeficiency virus (HIV) or cancer vaccines. Four experienced laboratories in Paris compared their results with this method...
Source: Medicine & Law Weekly (2006-10-13)
|
